LESAKA TECHNOLOGIES INC (LSAK) Stock Fundamental Analysis

NASDAQ:LSAK • US64107N2062

4.67 USD
+0.01 (+0.21%)
Last: Feb 27, 2026, 08:16 PM
Fundamental Rating

3

LSAK gets a fundamental rating of 3 out of 10. The analysis compared the fundamentals against 97 industry peers in the Financial Services industry. Both the profitability and financial health of LSAK have multiple concerns. LSAK has a correct valuation and a medium growth rate.


Dividend Valuation Growth Profitability Health

1

1. Profitability

1.1 Basic Checks

  • LSAK had negative earnings in the past year.
  • In the past year LSAK had a positive cash flow from operations.
  • LSAK had negative earnings in each of the past 5 years.
  • The reported operating cash flow has been mixed in the past 5 years: LSAK reported negative operating cash flow in multiple years.
LSAK Yearly Net Income VS EBIT VS OCF VS FCFLSAK Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 100M -100M -200M -300M

1.2 Ratios

  • LSAK has a Return On Assets of -7.08%. This is amonst the worse of the industry: LSAK underperforms 83.67% of its industry peers.
  • The Return On Equity of LSAK (-27.61%) is worse than 81.63% of its industry peers.
  • LSAK has a Return On Invested Capital of 1.15%. This is comparable to the rest of the industry: LSAK outperforms 42.86% of its industry peers.
Industry RankSector Rank
ROA -7.08%
ROE -27.61%
ROIC 1.15%
ROA(3y)-7.46%
ROA(5y)-7.58%
ROE(3y)-26.7%
ROE(5y)-22.49%
ROIC(3y)N/A
ROIC(5y)N/A
LSAK Yearly ROA, ROE, ROICLSAK Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 -20 -40 -60 -80

1.3 Margins

  • LSAK has a worse Operating Margin (1.10%) than 69.39% of its industry peers.
  • LSAK's Gross Margin of 28.16% is in line compared to the rest of the industry. LSAK outperforms 50.00% of its industry peers.
  • LSAK's Gross Margin has declined in the last couple of years.
Industry RankSector Rank
OM 1.1%
PM (TTM) N/A
GM 28.16%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y2.47%
GM growth 5Y-2.05%
LSAK Yearly Profit, Operating, Gross MarginsLSAK Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 50 -50 -100 -150

3

2. Health

2.1 Basic Checks

  • LSAK has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
  • Compared to 1 year ago, LSAK has more shares outstanding
  • The number of shares outstanding for LSAK has been increased compared to 5 years ago.
  • The debt/assets ratio for LSAK is higher compared to a year ago.
LSAK Yearly Shares OutstandingLSAK Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20M 40M 60M 80M
LSAK Yearly Total Debt VS Total AssetsLSAK Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 500M 1B

2.2 Solvency

  • LSAK has an Altman-Z score of 2.11. This is not the best score and indicates that LSAK is in the grey zone with still only limited risk for bankruptcy at the moment.
  • Looking at the Altman-Z score, with a value of 2.11, LSAK is in the better half of the industry, outperforming 76.53% of the companies in the same industry.
  • A Debt/Equity ratio of 1.25 is on the high side and indicates that LSAK has dependencies on debt financing.
  • LSAK has a worse Debt to Equity ratio (1.25) than 60.20% of its industry peers.
Industry RankSector Rank
Debt/Equity 1.25
Debt/FCF N/A
Altman-Z 2.11
ROIC/WACC0.09
WACC12.86%
LSAK Yearly LT Debt VS Equity VS FCFLSAK Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 200M 400M 600M

2.3 Liquidity

  • LSAK has a Current Ratio of 1.57. This is a normal value and indicates that LSAK is financially healthy and should not expect problems in meeting its short term obligations.
  • With a decent Current ratio value of 1.57, LSAK is doing good in the industry, outperforming 69.39% of the companies in the same industry.
  • A Quick Ratio of 1.43 indicates that LSAK should not have too much problems paying its short term obligations.
  • Looking at the Quick ratio, with a value of 1.43, LSAK is in the better half of the industry, outperforming 68.37% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 1.57
Quick Ratio 1.43
LSAK Yearly Current Assets VS Current LiabilitesLSAK Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 200M 400M 600M 800M 1B

6

3. Growth

3.1 Past

  • LSAK shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 41.05%, which is quite impressive.
  • The Revenue has grown by 24.44% in the past year. This is a very strong growth!
  • LSAK shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 35.52% yearly.
EPS 1Y (TTM)41.05%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-60%
Revenue 1Y (TTM)24.44%
Revenue growth 3Y43.64%
Revenue growth 5Y35.52%
Sales Q2Q%21.74%

3.2 Future

  • The Earnings Per Share is expected to grow by 52.26% on average over the next years. This is a very strong growth
  • LSAK is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 19.87% yearly.
EPS Next Y225.08%
EPS Next 2Y127.49%
EPS Next 3Y52.26%
EPS Next 5YN/A
Revenue Next Year32.3%
Revenue Next 2Y19.87%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • The estimated forward Revenue growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
LSAK Yearly Revenue VS EstimatesLSAK Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 200M 400M 600M 800M
LSAK Yearly EPS VS EstimatesLSAK Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2021 2022 2023 2024 2025 2026 2027 2028 0 1 -1 2 -2 -3

4

4. Valuation

4.1 Price/Earnings Ratio

  • LSAK reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
  • The Price/Forward Earnings ratio is 12.26, which indicates a correct valuation of LSAK.
  • Compared to the rest of the industry, the Price/Forward Earnings ratio of LSAK is on the same level as its industry peers.
  • LSAK's Price/Forward Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 28.05.
Industry RankSector Rank
PE N/A
Fwd PE 12.26
LSAK Price Earnings VS Forward Price EarningsLSAK Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 -20 -40

4.2 Price Multiples

  • Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of LSAK indicates a somewhat cheap valuation: LSAK is cheaper than 67.35% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 10.06
LSAK Per share dataLSAK EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 4 6 8

4.3 Compensation for Growth

  • The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
  • LSAK's earnings are expected to grow with 52.26% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y127.49%
EPS Next 3Y52.26%

0

5. Dividend

5.1 Amount

  • LSAK does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

LESAKA TECHNOLOGIES INC

NASDAQ:LSAK (2/27/2026, 8:16:04 PM)

4.67

+0.01 (+0.21%)

Chartmill FA Rating
GICS SectorFinancials
GICS IndustryGroupFinancial Services
GICS IndustryFinancial Services
Earnings (Last)02-04
Earnings (Next)05-05
Inst Owners39.32%
Inst Owner ChangeN/A
Ins Owners3.78%
Ins Owner Change41.39%
Market Cap391.91M
Revenue(TTM)717.52M
Net Income(TTM)-49.86M
Analysts82.86
Price Target8.16 (74.73%)
Short Float %0.29%
Short Ratio2.78
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)16.67%
Min EPS beat(2)-145.1%
Max EPS beat(2)178.43%
EPS beat(4)1
Avg EPS beat(4)-96.81%
Min EPS beat(4)-222.55%
Max EPS beat(4)178.43%
EPS beat(8)2
Avg EPS beat(8)-48.45%
EPS beat(12)2
Avg EPS beat(12)-44.14%
EPS beat(16)4
Avg EPS beat(16)-49.98%
Revenue beat(2)2
Avg Revenue beat(2)5.97%
Min Revenue beat(2)5.56%
Max Revenue beat(2)6.38%
Revenue beat(4)4
Avg Revenue beat(4)21.91%
Min Revenue beat(4)2.32%
Max Revenue beat(4)73.38%
Revenue beat(8)5
Avg Revenue beat(8)10.97%
Revenue beat(12)6
Avg Revenue beat(12)6.39%
Revenue beat(16)10
Avg Revenue beat(16)13.13%
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)-50%
EPS NQ rev (3m)-50%
EPS NY rev (1m)0%
EPS NY rev (3m)1371.5%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0%
Revenue NY rev (1m)2.13%
Revenue NY rev (3m)13%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 12.26
P/S 0.55
P/FCF N/A
P/OCF 179.2
P/B 2.17
P/tB N/A
EV/EBITDA 10.06
EPS(TTM)-0.11
EYN/A
EPS(NY)0.38
Fwd EY8.16%
FCF(TTM)-0.22
FCFYN/A
OCF(TTM)0.03
OCFY0.56%
SpS8.55
BVpS2.15
TBVpS-1.94
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -7.08%
ROE -27.61%
ROCE 1.51%
ROIC 1.15%
ROICexc 1.32%
ROICexgc 4.77%
OM 1.1%
PM (TTM) N/A
GM 28.16%
FCFM N/A
ROA(3y)-7.46%
ROA(5y)-7.58%
ROE(3y)-26.7%
ROE(5y)-22.49%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y2.47%
GM growth 5Y-2.05%
F-Score6
Asset Turnover1.02
Health
Industry RankSector Rank
Debt/Equity 1.25
Debt/FCF N/A
Debt/EBITDA 4.2
Cap/Depr 44.36%
Cap/Sales 2.82%
Interest Coverage 0.35
Cash Conversion 4.08%
Profit Quality N/A
Current Ratio 1.57
Quick Ratio 1.43
Altman-Z 2.11
F-Score6
WACC12.86%
ROIC/WACC0.09
Cap/Depr(3y)62.46%
Cap/Depr(5y)69.58%
Cap/Sales(3y)2.88%
Cap/Sales(5y)2.8%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)41.05%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-60%
EPS Next Y225.08%
EPS Next 2Y127.49%
EPS Next 3Y52.26%
EPS Next 5YN/A
Revenue 1Y (TTM)24.44%
Revenue growth 3Y43.64%
Revenue growth 5Y35.52%
Sales Q2Q%21.74%
Revenue Next Year32.3%
Revenue Next 2Y19.87%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y36.84%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year2864.24%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-290.26%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-74.44%
OCF growth 3YN/A
OCF growth 5YN/A

LESAKA TECHNOLOGIES INC / LSAK FAQ

Can you provide the ChartMill fundamental rating for LESAKA TECHNOLOGIES INC?

ChartMill assigns a fundamental rating of 3 / 10 to LSAK.


What is the valuation status for LSAK stock?

ChartMill assigns a valuation rating of 4 / 10 to LESAKA TECHNOLOGIES INC (LSAK). This can be considered as Fairly Valued.


How profitable is LESAKA TECHNOLOGIES INC (LSAK) stock?

LESAKA TECHNOLOGIES INC (LSAK) has a profitability rating of 1 / 10.